Citizens Maintains Market Outperform on Privia Health Gr, Raises Price Target to $31
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
Citizens analyst Constantine Davides maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the price target from $30 to $31.
Citizens analyst Constantine Davides maintains Privia Health Gr (NASDAQ:PRVA) with a Market Outperform and raises the price target from $30 to $31.
